Intraperitoneal injection of class A TLR9 agonist enhances anti–PD-1 immunotherapy in colorectal peritoneal metastases is a research paper published in JCI Insight (2022). On theSindex it has a DataRank of 0. It has been cited 10 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Foundation for the National Institutes of Health
Grant: R01AI152044,R35GM127027,R01GM137203
NIGMS NIH HHS
Grant: R35 GM127027
NIGMS NIH HHS
Grant: R01 GM137203
NIAID NIH HHS
Grant: R01 AI152044
National Institutes of Health
Grant: 3R01GM137203-05S1
Preoperative exercise therapy triggers trained immunity in KCs via cholinergic anti-inflammatory pathway
National Institutes of Health
Grant: 1R35GM127027-01
Mechanisms of Immune Dysfunction after Trauma and Surgical Sepsis
National Institutes of Health
Grant: 1R01AI152044-01A1
Role of Toll-like Receptor 9 in Fibroblastic Reticular Cell-based Therapy for Intra-abdominal Sepsis
FWCI
1.26
Citation Percentile
0.8%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals